Bristol Pravachol Ads Cited In Missouri AG Investigation, Class Action Lawsuit
This article was originally published in The Pink Sheet Daily
Executive Summary
The DTC campaign misled consumers into purchasing pravastatin, the proposed class action complaint says. FDA challenged the claim that Pravachol would help prevent stroke in patients without heart disease in an August 2003 warning letter.